0001437749-20-011862.txt : 20200527
0001437749-20-011862.hdr.sgml : 20200527
20200527212854
ACCESSION NUMBER: 0001437749-20-011862
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190315
FILED AS OF DATE: 20200527
DATE AS OF CHANGE: 20200527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fraser Craig
CENTRAL INDEX KEY: 0001557420
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39290
FILM NUMBER: 20916775
MAIL ADDRESS:
STREET 1: AEGERION PHARMACEUTICALS, INC.
STREET 2: 101 MAIN STREET, SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/
CENTRAL INDEX KEY: 0000946486
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
BUSINESS PHONE: 2154889300
MAIL ADDRESS:
STREET 1: 2600 KELLY ROAD
STREET 2: SUITE 100
CITY: WARRINGTON
STATE: PA
ZIP: 18976
FORMER COMPANY:
FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/
DATE OF NAME CHANGE: 19971201
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19961121
FORMER COMPANY:
FORMER CONFORMED NAME: ANSAN INC
DATE OF NAME CHANGE: 19950609
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2019-03-15
2019-03-19
0000946486
WINDTREE THERAPEUTICS INC /DE/
WINT
0001557420
Fraser Craig
2600 KELLY ROAD
SUITE 100
WARRINGTON
PA
18976
1
1
President and CEO
Common Stock
2019-03-15
4
F
0
18023
0
D
63337
D
Common Stock
441
I
By Trust
Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
This amended Form 4 is being filed solely to report that the number of shares withheld for tax liability upon the vesting of an RSU award represented a disposition of 18,023 shares rather than 20,641 shares as was reported on the Form 4 filed on March 19, 2019. All other information remains the same. The amounts reflected on this Form 4 have not been adjusted for a 1-for-3 reverse stock split effective April 29, 2020.
/s/ Craig Fraser
2020-05-27